Curaleaf Holdings (OTC: CURLF)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-07 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | ||||||
REV | 337.553M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Curaleaf Holdings (OTCQX: CURLF) through any online brokerage.
There are no as such competitors for Curaleaf Holdings.
The latest price target for Curaleaf Holdings (OTCQX: CURLF) was reported by Cantor Fitzgerald on Tuesday, August 9, 2022. The analyst firm set a price target for 13.70 expecting CURLF to rise to within 12 months (a possible 123.13% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Curaleaf Holdings (OTCQX: CURLF) is $6.14 last updated August 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for Curaleaf Holdings.
Curaleaf Holdings’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Curaleaf Holdings.
Curaleaf Holdings is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.